Comprehensive eye surgery information and news
Send This Page:
Know a friend or family member that might also benefit from this information?
Use the simple form below to quickly tell your friends or family about this page...
What's Your Opinion?
State your view - vote in our opinion polls!
|
Bookmark This:
Click Here to add this page to your favorites!
Bookmark us to visit back frequently because we add new exciting articles to our site regularly.
New Article Feed:
Subscribe to our Eye Surgery RSS feed to keep up to date on the latest information.
Share Your Stories:
If you have an Eye Surgery story or experience you would like to share send it in here and we'll publish it on our site so everyone can benefit.
Simply Click Here to have your own articles, stories or rants published here at EyeSurgerySolutions.com! We don't mind what you want to say or how long/short your item is. We always enjoy hearing from our visitors and sharing your words on our site for others to benefit from.
Most importantly just have fun with it; we look at all submissions equally.
Share your stories and become a EyeSurgerySolutions.com author today!.
How To Reach Us:
If you need to ask us something simply click here to use our secure contact form.
We usually respond to contact requests within a 24 hour period.
Eye Surgery News
Medical News From Major Eye Surgery Industry Sources
Title: Eyes: Am I a Candidate for Refractive or Laser Eye SurgeryCategory: Health FactsCreated: 1/31/2005 5:58:00 AMLast Editorial Review: 6/30/2005
Three medical societies today advised patients taking certain drugs to treat prostate enlargement to inform their eye surgeon about these medications before undergoing eye surgery. These drugs can potentially cause complications during cataract surgery.
Patients who are using Flomax for treatment of prostate enlargement and are considering Refractive Lens Exchange - an alternative to Lasik laser eye surgery - need to notify their eye doctor they are taking or have taken the drug, according to the Council for Refractive Surgery Quality Assurance (CRSQA, www.USAEyes.org), a nonprofit patient advocacy.
Lux Biosciences, Inc. a privately held biotechnology company focused on the treatment of ophthalmic diseases, announced results from a Phase 1 human safety and an open-label pilot efficacy study of the company's potential best-in-class therapy for dry eye, LX214 (topical mixed nanomicellar formulation of voclosporin). Randomized, double-masked, placebo-controlled data from 30 healthy volunteers showed LX214 to be well tolerated at the two doses (0.02% and 0.
Injecting the eye with the corticosteroid triamcinolone appears effective in improving the vision of some patients with retinal vein occlusion, an important cause of vision loss that results from blockages in the blood vessels in the retina, according to two reports in the September issue of Archives of Ophthalmology, one of the JAMA/Archives journals.
An international team, led by researchers from the University of California, San Diego School of Medicine and the National Eye Institute, has discovered gene variants for glaucoma in a black population. The finding could lead to future treatments or a cure for this disease, which leads to blindness in two million Americans each year.
The artificial intelligence group at Freie Universität Berlin, under the direction of the computer science professor Raúl Rojas, has developed a new type of information system for blind and visually impaired individuals. Field trials are being carried out to optimize the device for future users. During the next six months it will be tested by 25 persons. The artificial intelligence group at Freie Universität is collaborating with a research group at the Telekom Laboratories headed by Dr.
Joint task force with ophthalmic and medical organizations to review patient quality of life after Lasik.
FDA issues warning letter after inspection of clinical trials for approval of new Visian ICL and review of adverse effects of current ICL.
Results: MIT engineers have designed a retinal implant for people who have lost their vision from retinitis pigmentosa or age-related macular degeneration, two of the leading causes of blindness. The retinal prosthesis would help restore some vision by electrically stimulating the nerve cells that normally carry visual input from the retina to the brain.
New survey shows websites not affiliated with a specific company preferred.
Title: For the Color Blind, a Ray of HopeCategory: Health NewsCreated: 9/16/2009 2:10:00 PMLast Editorial Review: 9/17/2009
Additional Online Resources
Visit Our Partner Sites Below
Featured Eye Surgery Articles
Contact Us | Sitemap | Privacy | Disclaimer
© Copyright 2006 EyeSurgerySolutions.com | All Rights Reserved.